In 2000, CONRAD established the Global Microbicide
Project (GMP) to help develop new microbicidal agents that specifically address
the needs and perspectives of women. GMP funding cames solely from the Bill & Melinda Gates Foundation to expedite
microbicide development. The main
objective of this project was is to develop vaginal methods that would
protect women against sexually transmitted infections, including HIV/AIDS. The
importance of this area of research for reproductive health was highlighted at
the 1994 United Nations Conference on Population Development in Cairo. This project has now come to an end; all
microbicide development efforts are being undertaken through CONRAD.
For more information about GMP, please contact:
Dr. Michael J.K. Harper
Director, GMP
CONRAD
1611 N.
Kent St., Suite 806
Arlington, VA 22209-2111
Phone: (703)
276-4022
Fax: (703) 524-4770
E-mail: mharper@conrad.org
|
